Mark your calendars for AMCP Nexus 2026!
Call for Proposal Submission Opens: Monday, March 30, 2026
Call for Proposal Submission Closes: Monday, May 11, 2026
PROPOSAL SUBMISSION REQUIREMENTS
CPE SESSION REQUIREMENTS
All presentations must:
- Adhere to the ACPE guidelines
- Incorporate interactivity throughout the presentation
- Have a PowerPoint Presentation on AMCP’s template with content that achieves all learning objectives.
- Be based on and reference the best available evidence.
- Give a balanced view of therapeutic options and/or programs and services.
FACULTY REMUNERATION
Faculty associated with accepted CPE session proposals will receive:
- One complimentary Nexus2026 registration.
- Reimbursement of reasonable speaking-related travel expenses at the discretion of AMCP (i.e., round-trip coach airfare, ground transportation, and one-night hotel stay).
Typically, 45-60 minute continuing pharmacy education session should have no more than two faculty. Sessions conducted primarily as short presentations plus panel discussions should have no more than three faculty (i.e., facilitator plus two panelists). AMCP reserves the right to limit the number of faculty in a session and/or the type and amount of remuneration provided. AMCP also reserves the right to conditionally accept proposals for which AMCP can recommend certain modifications to content and faculty.
HOW TO SUBMIT A PROPOSAL
Proposals must include ALL the requested elements found within the online form. Fields included on the online form are the following:
SESSION TITLE
A short, specific presentation title (without abbreviations) that indicates the nature of the presentation.
Example 1: Inflation Reduction Act Ripple Effects: Considerations for Patient Access and 340B
Example 2: Advancing Health Equity in Food Allergy Prevention and Treatment:
SESSION TOPIC AND SUBTOPIC
AMCP has provided a list of topic areas. Please select from the list a primary and secondary (optional) topic. If your proposal topic is not listed, please provide the keyword most closely related to it.
Example 1: Inflation Reduction Act Ripple Effects: Considerations for Patient Access and 340B
Topic: Inflation Reduction Act Subtopic: 340B
Example 2: Advancing Health Equity in Food Allergy Prevention and Treatment:
Topic: Immunology Subtopic: Health Equity
SESSION DESCRIPTION
A brief (no more than 150 words) session description suitable for inclusion in the final NEXUS 2026 website/app. The description should accurately reflect the session content and be worded in a way that entices the audience to attend.
Example for Title 1 above:
The Inflation Reduction Act (IRA) will create a ripple effect across Medicare Part D formulary design, impacting multiple key stakeholders. It is critical to understand potential unintended consequences of the IRA on these stakeholders, including patients, PBMs and health plans, and 340B covered entities. What does research evidence tell us about existing Part D access to Drug Price Negotiation Program (DPNP)-selected drugs and therapeutic alternatives? How will changing incentives amidst the IRA affect PBMs and health plans, and what will this mean for their business model and formulary design decisions? What will it mean for 340B covered entities and patients?
This session will explore the changing incentives in formulary structure and drug utilization as IRA implementation proceeds, with an eye toward patient access. Current research on access to DPNP-selected drugs and 2025 Part D formularies, as well as anticipated trends and impacts on healthcare stakeholders, will be discussed.
NEEDS ASSESSMENT/KNOWLEDGE GAP INFORMATION
A description (at least 300 words) of why the topic addressed in the proposed session is important to managed care pharmacists, as well as the “knowledge gap” that the session will fill. Include a minimum of three citations to published information or evidence.
LEARNING OBJECTIVES
Provide at least three measurable, specific learning objectives that define what pharmacists should be able to do at the completion of the proposed session.. The objectives should address the identified needs and knowledge gap.
Learning objectives should begin with a verb and complete the sentence, “At the completion of this activity, participants should be able to ….” The verbs should be appropriate for the proposed session activity type (knowledge-based or application-based).
Knowledge-based CPE activities are primarily constructed to transmit knowledge (i.e., facts) and should only use verbs classified as knowledge-based. Application-based activities are constructed to apply (i.e., case studies, workshops, hands-on) the information learned in the time frame allotted and may use a mix of verbs classified as knowledge-based and application-based; however, the majority should be application-based.
For example, for a knowledge-based activity for the Example description above, the following objectives are appropriate:
At the completion of this activity, participants should be able to:
- Discuss changing incentives for Medicare Part D plan coverage of Drug Price Negotiation Program (DPNP)-selected drugs and therapeutic alternatives (TAs) as maximum fair prices go into effect and their potential impact on benefit design and patient access.
- Identify the potential impact of the DPNP on 340B margin and the likely impacts for patients at 340B covered entities.
- Describe early signals of overall changes to Medicare Part D formulary coverage amidst the IRA’s Part D benefit redesign.
CONFIRMED FACULTY
Please provide the confirmed faculty with their place of employment and a short bio. These faculty members agree to speak at NEXUS 2026 and are available during the conference dates. AMCP will not review or accept proposals where faculty have been invited, but not confirmed. The faculty members proposed should have a balanced view and include a managed care perspective.
If the proposed session has multiple faculty, the submitter is designated as the session coordinator. If the proposal is accepted, this person will serve as the main liaison with AMCP and will be responsible for ensuring that all requested information is submitted in a timely manner.
Submitters may either enter all faculty information themselves or invite faculty to enter and update their own information in the submission platform. Required faculty information includes contact information, professional information, a bio, and disclosure of relevant financial relationships. The submitter remains responsible for ensuring that all required information is complete for each faculty member.
DETAILED PROGRAM AGENDA
New this year: You may indicate a preference for either a 45-minute or 60-minute session. Please note final session length may be adjusted upon acceptance.
Outline what information will be covered by each faculty presenter, and for how long. Please remember to account for housekeeping and question-and-answer time.
BEST PRACTICES AND OUTCOMES
Indicate if the content will provide research outcomes and/or best practices, and explain.
KEY TAKEAWAYS
Indicate the three top takeaways for advancing the practice of managed care pharmacy. This should not be a repeat of the learning objectives.
DISCLOSURE OF COMMERCIAL INTEREST SUPPORT
Provide disclosure of any financial support from a commercial interest (e.g., pharmaceutical industry) for any original research or data proposed. Note: If accepted, all faculty will be required to complete a disclosure of relevant financial relationships form.
DEADLINE
Proposals must be submitted no later than 11:59 pm PT on Monday, May 11, 2026
EVALUATION OF PROPOSALS
The AMCP education staff and Educational Affairs Committee will evaluate CPE proposals. Criteria for review include, but are not limited to, topic relevancy to the managed care professional, risk of promotional bias, faculty expertise listed, and timeliness.
Acceptance and rejection notifications will be sent the week of July 6, 2026.
QUESTIONS?
Please direct questions related to education@amcp.org.